 |
市场调查报告书
商品编码
1673938
医药溶剂市场：按类型、应用和地区划分Pharmaceutical Solvents Market, By Type, By Application, By Geography |
||||||
价格
简介目录
2025 年全球医药溶剂市场规模预计为 40 亿美元，预计到 2032 年将达到 58.9 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 5.7%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 40亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025 年至 2032 年复合年增长率 | 5.70% | 2032 年金额预测 | 58.9 亿美元 |
数字。 2025 年各地区医药溶剂市场占有率（%）
溶剂在製药业中发挥至关重要的作用，广泛应用于药物的生产。它作为化学合成中的反应介质，也用于溶解和提取活性药物成分。常用的溶剂有水、甲醇、乙醇、丙醇、丁醇、环己烷、二氯甲烷、氯仿、丙酮、乙酸乙酯、丁酮等。全球对药品和生技药品的需求不断增长，导致製药公司越来越多地将其製造业务外包。预计这将推动契约製造和研究机构对医药级溶剂的需求。此外，有关使用有毒溶剂的严格安全和环境法规可能需要转向更安全的替代品，从而推动医药溶剂市场的发展。
市场动态
全球医药溶剂市场受到全球医药生产扩张的推动。学名药的快速成长和契约製造的增加导致製药商对溶剂的需求大幅增加。然而，有关使用有害有机溶剂的严格环境法规是一个障碍。包括印度和中国在内的许多国家已禁止在製药应用中使用甲醇、苯和四氯化碳等有毒溶剂，因为它们可能带来健康风险。这为生物基和环保溶剂进入市场创造了机会。新冠疫情期间，供应链中断暂时影响了原料的可得性，对市场成长产生了负面影响。然而，正在进行的疫苗接种运动和卫生服务的恢復正在推动整体药物需求。
研究的主要特点
- 本报告对全球医药溶剂市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（以十亿美元计）和年复合成长率（CAGR%），以 2024 年为基准年。
- 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 全球製药溶剂市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球製药溶剂市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员可以透过全球製药溶剂市场分析中使用的各种策略矩阵来促进决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- 一致的机会图 (COM)
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- PEST分析
- 波特五力分析
- 市场机会
- 监管情景
- 产业趋势
第四章 全球製药溶剂市场-冠状病毒（COVID-19）大流行的影响
- 介绍
- 影响全球医药溶剂市场的因素-COVID-19
- 影响分析
第 5 章 全球医药溶剂市场（按类型），2020 年至 2032 年
- 介绍
- 酒精
- 胺
- 芳香烃
- 氯化溶剂
- 其他的
6. 全球医药溶剂市场（按应用划分）2020 年至 2032 年
- 介绍
- 活性药物成分 (API)
- 配方
- 研究与开发
- 其他的
7. 2020 年至 2032 年全球医药溶剂市场（按地区划分）
- 介绍
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- 热图分析
- 市场占有率分析（3x3 矩阵）
- 公司简介
- BASF SE
- Dow Chemical Company
- Merck Group
- Eastman Chemical Company
- Solvay SA
- Huntsman Corporation
- LyondellBasell Industries NV
- Evonik Industries AG
- Ashland Global Holdings Inc.
- INEOS Group Limited
- Sigma-Aldrich（Merck KGaA）
- Mitsubishi Gas Chemical Company, Inc.
- Shell Chemicals
- Arkema SA
- Tosoh Corporation
- Afton Chemical Corporation
- Clariant AG
- Kuraray Co., Ltd.
- Albemarle Corporation
- KMG Chemicals
第 9 章分析师建议
- 兴衰
- 一致的机会地图
第 10 章 章节
- 参考
- 调查方法
简介目录
Product Code: CMI3925
Global Pharmaceutical Solvents Market is estimated to be valued at USD 4.00 Bn in 2025 and is expected to reach USD 5.89 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.00 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.70% | 2032 Value Projection: | USD 5.89 Bn |
Figure. Pharmaceutical Solvents Market Share (%), By Region 2025
Solvents play a vital role in the pharmaceutical industry as they are used widely in manufacturing drugs and medicines. They act as reaction media for chemical syntheses and are also used to solubilize and extract active pharmaceutical ingredients. Common solvents employed include water, methanol, ethanol, propanol, butanol, cyclohexane, dichloromethane, chloroform, acetone, ethyl acetate, and methyl ethyl ketone among others. With the rising global demand for medicines and biological drugs, pharmaceutical companies are increasingly outsourcing their manufacturing activities. This is expected to boost the demand for pharmaceutical-grade solvents across contract manufacturing and research organizations. Moreover, stricter safety and environmental regulations regarding the use of toxic solvents may necessitate switching to safer alternative solvents, thereby propelling the pharmaceutical solvents market forward.
Market Dynamics:
The global pharmaceutical solvents market is driven by the expanding pharmaceutical production worldwide. Rapid growth of the generics industry and rising contract manufacturing have significantly increased the demand for solvents from drug makers. However, stringent environmental regulations regarding the use of hazardous organic solvents act as a restrain. Many countries India and china and other, have banned toxic solvents like methanol, benzene, and carbon tetrachloride from pharmaceutical applications due to associated health risks. This has created opportunities for bio-based and eco-friendly solvents to enter the market. Supply chain disruptions during the COVID-19 pandemic temporarily impacted the availability of raw materials, negatively impacting the market growth. But ongoing vaccination drives and recovery of healthcare services are boosting the overall pharmaceutical demand.
Key Features of the Study:
- This report provides in-depth analysis of the global pharmaceutical solvents market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pharmaceutical solvents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include BASF SE, Dow Chemical Company, Merck Group, Eastman Chemical Company, Solvay S.A., Huntsman Corporation, LyondellBasell Industries N.V., Evonik Industries AG, Ashland Global Holdings Inc., INEOS Group Limited, Sigma-Aldrich (Merck KGaA), Mitsubishi Gas Chemical Company, Inc., Shell Chemicals, Arkema S.A., Tosoh Corporation, Afton Chemical Corporation, Clariant AG, Kuraray Co., Ltd., Albemarle Corporation, and KMG Chemicals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pharmaceutical solvents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical solvents market
Detailed Segmentation-
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Alcohols
- Amines
- Aromatic Hydrocarbons
- Chlorinated Solvents
- Others
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Active Pharmaceutical Ingredients (APIs)
- Formulations
- Research & Development
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- BASF SE
- Dow Chemical Company
- Merck Group
- Eastman Chemical Company
- Solvay S.A.
- Huntsman Corporation
- LyondellBasell Industries N.V.
- Evonik Industries AG
- Ashland Global Holdings Inc.
- INEOS Group Limited
- Sigma-Aldrich (Merck KGaA)
- Mitsubishi Gas Chemical Company, Inc.
- Shell Chemicals
- Arkema S.A.
- Tosoh Corporation
- Afton Chemical Corporation
- Clariant AG
- Kuraray Co., Ltd.
- Albemarle Corporation
- KMG Chemicals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Pharmaceutical Solvents Market - Impact of Coronavirus (COVID-19) Pandemic
- Overview
- Factors Affecting the Global Pharmaceutical Solvents Market - COVID-19
- Impact Analysis
5. Global Pharmaceutical Solvents Market, By Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Alcohols
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Amines
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Aromatic Hydrocarbons
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Chlorinated Solvents
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
6. Global Pharmaceutical Solvents Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Active Pharmaceutical Ingredients (APIs)
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Formulations
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Research & Development
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
7. Global Pharmaceutical Solvents Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Market Size and Forecast, By Type, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Application, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020- 2032, (US$ Bn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Market Size and Forecast, By Type, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Application, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020- 2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Market Size and Forecast, By Type, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Application, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020- 2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Market Size and Forecast, By Type, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Application, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020- 2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Market Size and Forecast, By Type, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Application, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020- 2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Market Size and Forecast, By Type, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Application, 2020- 2032, (US$ Bn)
- Market Size and Forecast, By Country/Region, 2020- 2032, (US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- BASF SE
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Dow Chemical Company
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Merck Group
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Eastman Chemical Company
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Solvay S.A.
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Huntsman Corporation
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- LyondellBasell Industries N.V.
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Evonik Industries AG
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Ashland Global Holdings Inc.
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- INEOS Group Limited
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Sigma-Aldrich (Merck KGaA)
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Mitsubishi Gas Chemical Company, Inc.
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Shell Chemicals
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Arkema S.A.
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Tosoh Corporation
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Afton Chemical Corporation
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Clariant AG
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Kuraray Co., Ltd.
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- Albemarle Corporation
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- KMG Chemicals
- Company Overview
- Type Portfolio
- Recent Developments/Updates
- BASF SE
9. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. Section
- References
- Research Methodology
- About Us and Sales Contact
02-2729-4219
+886-2-2729-4219
